# Sunshield Chemicals share price today (Sunshield Chemicals Ltd, NSE: SUNSHIEL)

> Sunshield Chemicals share price today: ₹1,030.00 at the NSE close on 3 November 2026, down 0.1% in a year. Sunshield Chemicals (NSE: SUNSHIEL) is worth ₹906 crore, trades at a P/E of 24.9 and has closed between ₹745.70 and ₹1,277.05 over the past 52 weeks. > Sunshield Chemicals Ltd's results are improving, while its P/E is near the low end of its own history over 8.4 years, higher than only 17% of past readings. SUNSHIEL · Speciality Chemicals · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/sunshield-chemicals-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from the last 12 quarters
- Price: ₹1,030.00 (−0.1% in a year)
- P/E: 24.9× (lower than 83% of the last 8.4 years)
- Revenue (Jun 2026): ₹127 Cr (+11.4% on a year ago)
- Profit (Jun 2026): ₹13.0 Cr (+85.7% on a year ago)
- Operating margin: 16.0% (+5.0 points on a year ago)
- ROCE: 20%, FY26
- ROIC: 15.3%, against a 12.0% cost of capital: +3.3 points

The main question: yearly earnings per share moved +103.1% while the share price moved −0.1%. ## What is the Sunshield Chemicals share price today? Sunshield Chemicals Ltd's share price was ₹1,030.00 at the close on 3 November 2026. It has been rising for 22 weeks. That is 1.6% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹746 and ₹1,277, and at that close it sat 54% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 4 weeks running. Over the last 11 years the share price moved +224% while the NIFTY 500 moved +251%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 9 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Sunshield Chemicals this quarter? Three changes stood out: best operating margin in 10 quarters, promoters raised their stake for 4 quarters in a row and highest quarterly profit in 15 quarters. 1. Best operating margin in 10 quarters Operating margin was 16% in the June 2026 quarter, against 11% a year earlier. 2. Promoters raised their stake for 4 quarters in a row From 64.5% to 66.6% of the company by the September 2026 quarter. 3. Highest quarterly profit in 15 quarters Profit of ₹13 crore in the June 2026 quarter is the highest of the last 15 quarters. ## What are Sunshield Chemicals' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Sunshield Chemicals reported revenue of ₹127 crore, up 11.4% from ₹114 crore a year earlier, and a profit of ₹13.0 crore, up 85.7% from ₹7.00 crore. ### Sunshield Chemicals results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹127 crore | ₹114 crore | +11.4% |
| Profit | ₹13.0 crore | ₹7.00 crore | +85.7% |
| Earnings per share | ₹15.34 | ₹7.75 | +97.9% |
| Operating margin | 16.0% | 11.0% | +5.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Sunshield Chemicals share price history? Sunshield Chemicals closed at ₹1,030.00 on 3 November 2026, down 0.1% from ₹1,031.20 a year earlier (31 October 2025) and up 193.8% over five years. Its highest weekly close since March 2016 was ₹1,277.05 on 18 August 2026. ### Sunshield Chemicals share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹941.70 | +9.4% |
| 1 month ago · 1 Oct 2026 | ₹1,060.30 | −2.9% |
| 1 year ago · 31 Oct 2025 | ₹1,031.20 | −0.1% |
| 3 years ago · 3 Nov 2023 | ₹780.26 | +32.0% |
| 5 years ago · 4 Nov 2021 | ₹350.62 | +193.8% |
| 10 years ago · 4 Nov 2016 | ₹322.45 | +219.4% |
| Earliest weekly close in our records · 11 Mar 2016 | ₹317.87 | +224.0% |
| Highest weekly close since March 2016, also the 52-week high · 18 Aug 2026 | ₹1,277.05 | −19.3% |
| Lowest weekly close since March 2016 · 27 Mar 2020 | ₹73.65 | +1,298.5% |
| 52-week low (weekly close) · 27 Mar 2026 | ₹745.70 | +38.1% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (542 weekly closes from 11 March 2016 to 3 November 2026.)

## What is the latest news on Sunshield Chemicals? 3 Nov 2026: Sunshield Chemicals closed at ₹1,030.00, up 9.4% on the week and down 2.9% on the month. Our read, 19 Jul 2026: Revenue grew from 199 Cr in FY21 to 366 Cr in FY25 as the company commissioned 128 Cr of cumulative capital spending funded entirely from operating cash flows. Operating margin troughed at 8% in Dec 2024 as the new asset base was being absorbed, and has since recovered to 11.5% in Sep 2025, a trajectory consistent with fixed-cost operating leverage on rising utilization. ### Earlier

- Results for April to June 2026: Revenue up 11.4% and profit up 85.7% on a year earlier. ### Our read of the business

Revenue grew from 199 Cr in FY21 to 366 Cr in FY25 as the company commissioned 128 Cr of cumulative capital spending funded entirely from operating cash flows. Operating margin troughed at 8% in Dec 2024 as the new asset base was being absorbed, and has since recovered to 11.5% in Sep 2025, a trajectory consistent with fixed-cost operating leverage on rising utilization. October to December 2025: Seasonal revenue softness at 95 Cr; GPM held at 26.2% confirming volume, not raw material, drove operating margin compression. (Our read after the October to December 2025 results, written 19 July 2026. The April to June 2026 results are out since, so this part may be out of date until we update it.)

## What dividend does Sunshield Chemicals pay? The NSE corporate-actions record has no dividend for Sunshield Chemicals since 1 April 2021, so this page cannot show amounts per share. Yes. Sunshield Chemicals Ltd paid out 9% of its profit as dividends in FY26, and it paid a dividend in 5 of its last 13 reported years. (From the NSE corporate-actions record, read 4 November 2026.)

## What could change the Sunshield Chemicals story? What are the risks? Operating margin falls back below 8% for two consecutive quarters while revenue stays above 100 Cr per quarter, ruling out the operating leverage thesis and implying a structural cost impairment not visible from the GPM stability, or borrowings reaccelerate above 120 Cr while quarterly operating cash flow drops below 10 Cr, indicating the capital spending cycle is reigniting without revenue conversion. ### Each change stops working if

- : Revenue reverts below 90 Cr per quarter for two consecutive periods while CWIP continues rising, indicating the new lines are not absorbing. - : GPM drops below 22% for two consecutive quarters, signalling raw material inflation is now the primary driver of margin pressure rather than operating leverage. - : FII ownership falls below 5% for two consecutive quarters, reversing the accumulation pattern. ### The main risks

- : Zero concall availability means the margin recovery thesis cannot be confirmed or challenged from management commentary. ⚠ estimate
- : Dec 2025 revenue at 95 Cr was 22% below Sep 2025's 122 Cr, larger than the prior year's seasonal dip, raising uncertainty about the pace of recovery. ⚠ estimate
- : Data is 135 days stale with two quarters (Mar and Jun 2026) missing, the thesis cannot reflect anything that happened after Dec 2025. ⚠ estimate

(Our read after the October to December 2025 results, written 19 July 2026. The April to June 2026 results are out since, so this part may be out of date until we update it.)

## What to watch in Sunshield Chemicals' next results? When Sunshield Chemicals reports July to September 2026, these are the 3 checks that show whether the story is still on course. First: Company files financial results for Mar 2026 and Jun 2026 quarters without any accompanying shareholder note or concall. - What to check ()
- Company files financial results for Mar 2026 and Jun 2026 quarters without any accompanying shareholder note or concall. - Operating margin below 8.5% for two consecutive quarters despite revenue above 100 Cr. - Mar 2026 results filed with revenue below 95 Cr and operating margin below 9%, indicating Dec 2025 was not a seasonal trough. ## Which stock lists is Sunshield Chemicals on? Sunshield Chemicals is not on any of our India lists this week. ## Is Sunshield Chemicals profitable? Sunshield Chemicals Ltd earned ₹13.0 Cr of net profit in the Jun 2026 quarter, +85.7% on the same quarter a year earlier. That is the 5th quarter in a row of profit growth. Full-year FY26 profit was ₹30.0 Cr. That is 10.2% of the quarter's revenue. The same quarter a year earlier earned ₹7.0 Cr. For the full year, FY26 profit was ₹30.0 Cr (+100.0% on the year before). Why profit moved: revenue changed +11.4% on a year earlier and the margin moved +5.0 percentage points. Most of the change came from keeping more of each sale. On average over the last four quarters, profit changed +113.1% and revenue +13.6%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit. FY26-Q4. revenue ₹110 Cr and profit ₹11 Cr as reported. FY27-Q1. revenue ₹127 Cr and profit ₹13 Cr as reported. Why-sources: our stock research file (19 July 2026) and the company’s own results for those quarters. ## How much revenue does Sunshield Chemicals make, and is it growing? Sunshield Chemicals Ltd reported ₹127 Cr of revenue in the Jun 2026 quarter, +11.4% on the same quarter a year earlier. Over 10 years it has grown 11.4% a year on average. The last full year, FY26, came in at ₹441 Cr. The last four reported quarters add to ₹454 Cr. FY26 revenue was ₹441 Cr, +20.5% on the year before. Recent pace: the last four quarters grew +13.6% on average, against 11.4% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +12.9%, against +24.1% a year over the last 8 quarters (rolling over); profit over the last 12 months grew +100.0%, against +37.6% a year (accelerating). FY26-Q4. revenue ₹110 Cr and profit ₹11 Cr as reported. FY27-Q1. revenue ₹127 Cr and profit ₹13 Cr as reported. Why-sources: our stock research file (19 July 2026) and the company’s own results for those quarters. ## How much of every ₹100 of sales does Sunshield Chemicals keep? Sunshield Chemicals Ltd's operating margin was 16.0% in the Jun 2026 quarter, 5.0 percentage points higher than the same quarter a year ago. Across 13 years it has been between 1.8% and 15.0%. The latest quarter is above every full year in that period. Why the margin moved: operating margin changed +5.0 percentage points on the year while gross margin changed +4.2 points. So the gain came mostly from the gross margin, which means input costs and prices charged. FY26-Q4. revenue ₹110 Cr and profit ₹11 Cr as reported. FY27-Q1. revenue ₹127 Cr and profit ₹13 Cr as reported. Why-sources: our stock research file (19 July 2026) and the company’s own results for those quarters. ## Is Sunshield Chemicals' profit turning into cash? Over the last 3 years, 156% of Sunshield Chemicals Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹10.0 Cr of operating cash against ₹30.0 Cr of profit. After ₹10.0 Cr of spending on assets, ₹0.0 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 156% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle. What to look at next: the bigger use of cash is spending on new assets, at 4.0× depreciation over three years. The next section checks what that spending is building. ## Where does Sunshield Chemicals' cash go? Sunshield Chemicals Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 76 days in FY26, up from 69 days in FY21. It spent ₹111 Cr on assets over the last 3 years. Customers take 59 days to pay, and stock sits for 59 days on average. Why this happened. Five years of OCF-funded capex (cumulative 128 Cr) produced fixed assets of 128 Cr and CWIP of 37 Cr by Sep 2025. Revenue followed: 199, 244, 245, 283, 366 Cr over FY21 to 25. Quarterly revenue has stabilized at 110 to 122 Cr per quarter in Mar, Sep 2025 against a prior run rate of 78 to 93 Cr in the FY25 trough quarters. The capex cycle appears to be moderating as borrowings peaked at 100 Cr and repaid to 88 Cr. At FY26 sales of ₹441 Cr, each day of that cycle ties up about ₹1.2 Cr, so roughly ₹92.0 Cr is tied up in the business at any time. FY26: customers took 59 days to pay and stock sat for 59 days, about 1.9 months of sales sitting as stock, for a full cycle of 76 days, longer than FY21's 69. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 59 days. Customers pay about 59 days after that. Suppliers are paid at 42 days. Together that makes the 76-day cycle. Spending on assets: ₹111 Cr over the last 3 years, against ₹28.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹6.0 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Sunshield Chemicals' P/E ratio, and how does it compare with its own history? Sunshield Chemicals Ltd's P/E is 24.9×, near the low end of its own history: it has been lower only 17% of the time. Its usual P/E (the middle reading) is 38.5×, over 8.4 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +103.1% while the price moved −0.1%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved +24.1% a year; about +16.7% a year came from earnings growth and about +7.4 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## What growth does the Sunshield Chemicals share price assume? Worked out from its price on 27 August 2026, Sunshield Chemicals Ltd's share price assumed profit growth of about 18.7% a year. Today its P/E is 24.9×, lower than 83% of its own last 8.4 years. This is a one-day reading, taken on 27 August 2026. Every other number on this page, the multiple included, uses the latest price as of 3 November 2026. A higher price assumes more growth and a lower price less, so it changes whenever the price changes, and this page does not update it between measurements. ## Is the Sunshield Chemicals business getting better or worse? Sunshield Chemicals Ltd's business is giving mixed signals. Eps growth is rising at +108.9% while revenue growth is slowing from its peak at +12.9%, so the lines disagree and each one tells part of the story. This is based on 12 quarters of 4 measures. Why it matters: when the lines disagree, each line above matters more than any single label. ## What is the Sunshield Chemicals story, and has it been checked? Sunshield Chemicals Ltd's story is not scored yet against the checks our research set on 19 July 2026. Where it sits in its own cycle: Not stated in the research file. Our read, 19 July 2026. From the numbers. From the price. Price stage 2, week 22, below its 200-day line, relative strength falling. From the research. Sunshield Chemicals is mid-cycle in an earnings recovery, with revenue nearly doubling over four years on new capacity and OCF of 3.2x net profit confirming cash-backed growth, trading at the 31st percentile of a…

Where they disagree. What is proven. What is not proven yet. OPM falls back below 8% for two consecutive quarters while revenue stays above 100 Cr per quarter, ruling out the operating leverage thesis and implying a structural cost impairment not visible from the GPM stability, or borrowings reaccelerate above 120 Cr while quarterly OCF drops below 10 Cr, indicating the capex cycle is reigniting without revenue conversion. What would change our mind. OPM falls back below 8% for two consecutive quarters while revenue stays above 100 Cr per quarter, ruling out the operating leverage thesis and implying a structural cost impairment not visible from the GPM stability, or borrowings reaccelerate above 120 Cr while quarterly OCF drops below 10 Cr, indicating the capex cycle is reigniting without revenue conversion. What the company does. Revenue grew from 199 Cr in FY21 to 366 Cr in FY25 as the company commissioned 128 Cr of cumulative capex funded entirely from operating cash flows. OPM troughed at 8% in Dec 2024 as the new asset base was being absorbed, and has since recovered to 11.5% in Sep 2025, a trajectory consistent with fixed-cost operating leverage on rising utilization. What the surface reading misses. The surface reading is: TTM PAT growth of 66.5% looks like strong acceleration. The research reads it further: All 13 one off ledger quarters are clean, zero exceptional items in any period. Operating profit also grew: TTM operating profit rose from 28.19 Cr (Dec 2024 TTM) to 47.24 Cr (Dec 2025 TTM), a 68% move mirroring PAT. The growth is from revenue volume and operating leverage, not a tax or exceptional distortion. What the surface reading misses. Sources: our stock research file (19 July 2026) · quarterly results through Jun 2026. The story check is re-scored every results season; the record below never changes. ## What is Sunshield Chemicals management's track record? No company-specific SEBI, fraud or enforcement action surfaced in the current sweep. Sources:

- [screener.in](https://www.screener.in/company/530845/)
- [sebi.gov.in](https://www.sebi.gov.in/sebiweb/home/HomeAction.do?doListing=yes&sid=2&smid=2&ssid=9)
- [upstox.com](https://upstox.com/stocks/sunshield-chemicals-ltd-shareholding)

(Checked 30 August 2026.)

## How much does Sunshield Chemicals earn on its capital? Sunshield Chemicals Ltd earned a ROCE of 20% in FY26. That is up from a low of −1% in FY15. Its return on capital used (ROIC) is 3.3 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 6.8% net margin and 1.45× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 6.8% net margin × 1.45× asset turnover × 1.21× leverage (assets divided by equity) ≈ 11.9% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 15.3% − 12.0% = +3.3 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error. ## Does Sunshield Chemicals have too much debt? Sunshield Chemicals Ltd has total debt of ₹88.0 Cr against shareholder equity of ₹108 Cr as of Dec 2025, so its debt is 0.81× its equity. Year by year, that ratio went from 1.46 in FY22 to 1.04 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Sunshield Chemicals shareholding pattern? Promoters raised their stake in Sunshield Chemicals Ltd by 4.2 percentage points over 8 quarters, the biggest change among its owners. Promoters now own 66.6% of the company. Foreign institutions moved +3.7 points over the same period, to 9.1%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Why this happened. FII ownership rose from 1.67% in Mar 2023 to 8.01% in Sep 2025 in five observable steps, no reversal quarter. Simultaneously, promoter stake rose from 62.36% to 64.45%, funded from the reduction in public float (35.95% to 27.52%). Both classes accumulated at trough margins, aligning with the thesis. Over the last two years: Promoters: +4.2 points over 8 quarters, to 66.6%; Foreign institutions: +3.7 points over 8 quarters, to 9.1%; Domestic institutions: +0.0 points over 8 quarters, to 0.0%. Why the owners changed: promoters drove it (+4.2 points), together with foreign institutions (+3.7 points). They raised their stake step by step. ## How far is Sunshield Chemicals from balance-sheet trouble? For Sunshield Chemicals Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Sunshield Chemicals rank in its industry? 64.0 out of 100, rank 4 of 30 in Speciality Chemicals, with 81% of the evidence available. Sunshield Chemicals Ltd scores 64.0 out of 100 against the 30 companies it is compared with in Speciality Chemicals, ranking 4. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 23.6 + 18.8 + 10.8 + 10.8 = 64. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Sunshield Chemicals compared with? Sunshield Chemicals ranks 4 of 30 Speciality Chemicals companies on the 4-Factor Sector Score, with 64.0 out of 100. 1. [Panama Petrochem Ltd](https://www.sectoralpha.in/stocks/panama-petrochem-ltd) PANAMAPET · turning · Sector-leading setup · 96% evidence 80.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.8/35 · Revenue 45.9% · Profit 100% · Operating margin change 14 points · 88% evidence Capital efficiency 15.9/25 · ROCE 19.2% · Operating margin 22% · 100% evidence Valuation 19.7/20 · P/E 5.7× · PEG 0.18 · 100% evidence Relative strength 13.9/20 · Lead over its industry 16.3% · Lead over NIFTY 500 31.3% · 1 year 68.1% · 100% evidence · 10 of 12 weeks ahead Exact sum: 30.8 + 15.9 + 19.7 + 13.9 = 80.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Yasho Industries Ltd](https://www.sectoralpha.in/stocks/yasho-industries-ltd) YASHO · losing its lead · Most evidence points up · 78% evidence 67.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.0/35 · Revenue 54.2% · Profit 100% · Operating margin change 3 points · 100% evidence Capital efficiency 12.3/25 · ROCE 8.9% · Operating margin 21% · 100% evidence Valuation 12.7/20 · P/E 45× · PEG 1.02 · 65% evidence Relative strength 12.2/20 · Lead over its industry n/a · Lead over NIFTY 500 41.1% · 1 year 103.4% · 25% evidence · 11 of 12 weeks ahead Exact sum: 30 + 12.3 + 12.7 + 12.2 = 67.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Vikram Thermo (India) Ltd](https://www.sectoralpha.in/stocks/vikram-thermo-indialtd) breaking out · Evidence leans up · 68% evidence 64.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.8/35 · Revenue 16.9% · Profit 41.9% · Operating margin change 8 points · 83% evidence Capital efficiency 21.3/25 · ROCE 36.2% · Operating margin 48% · 95% evidence Valuation 6.6/20 · P/E 25.8× · PEG n/a · 50% evidence Relative strength 12.5/20 · Lead over its industry n/a · Lead over NIFTY 500 74.5% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 23.8 + 21.3 + 6.6 + 12.5 = 64.2 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 4. Sunshield Chemicals Ltd this page SUNSHIEL · quiet · Evidence leans up · 81% evidence 64.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 12.9% · Profit 100% · Operating margin change 5 points · 88% evidence Capital efficiency 18.8/25 · ROCE 19.9% · Operating margin 16% · 100% evidence Valuation 10.8/20 · P/E 24.3× · PEG 2.21 · 100% evidence Relative strength 10.8/20 · Lead over its industry n/a · Lead over NIFTY 500 4.3% · 1 year -4% · 25% evidence · 0 of 5 weeks ahead Exact sum: 23.6 + 18.8 + 10.8 + 10.8 = 64 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Black Rose Industries Ltd](https://www.sectoralpha.in/stocks/black-rose-industries-ltd) BLACKROSE · quiet · Evidence leans up · 81% evidence 60.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 8.6% · Profit 28.6% · Operating margin change 6 points · 88% evidence Capital efficiency 16.4/25 · ROCE 18.7% · Operating margin 16% · 100% evidence Valuation 10.0/20 · P/E 17.1× · PEG 4.96 · 100% evidence Relative strength 10.9/20 · Lead over its industry n/a · Lead over NIFTY 500 4.4% · 1 year n/a · 25% evidence · 7 of 12 weeks ahead Exact sum: 23.6 + 16.4 + 10 + 10.9 = 60.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Tatva Chintan Pharma Chem Ltd](https://www.sectoralpha.in/stocks/tatva-chintan-pharma-chem-ltd) TATVA · losing its lead · Evidence leans up · 93% evidence 60.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.7/35 · Revenue 49.2% · Profit 100% · Operating margin change 1 points · 100% evidence Capital efficiency 8.7/25 · ROCE 7.2% · Operating margin 19% · 100% evidence Valuation 11.3/20 · P/E 60.2× · PEG 1.21 · 65% evidence Relative strength 11.4/20 · Lead over its industry 7.8% · Lead over NIFTY 500 23.3% · 1 year 15.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 28.7 + 8.7 + 11.3 + 11.4 = 60.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Aether Industries Ltd](https://www.sectoralpha.in/stocks/aether-industries-ltd) AETHER · leader · Evidence leans up · 90% evidence 59.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.4/35 · Revenue 30.2% · Profit 28.4% · Operating margin change 1 points · 100% evidence Capital efficiency 12.8/25 · ROCE 11.9% · Operating margin 32% · 100% evidence Valuation 9.7/20 · P/E 85.1× · PEG n/a · 50% evidence Relative strength 14.8/20 · Lead over its industry 22.3% · Lead over NIFTY 500 38.6% · 1 year 114.4% · 100% evidence · 12 of 12 weeks ahead Exact sum: 22.4 + 12.8 + 9.7 + 14.8 = 59.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Privi Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/privi-speciality-chemicals-ltd) PRIVISCL · quiet · Evidence leans up · 82% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.7/35 · Revenue 17.5% · Profit 44.5% · Operating margin change -1 points · 95% evidence Capital efficiency 18.5/25 · ROCE 22.3% · Operating margin 26% · 76% evidence Valuation 10.1/20 · P/E 33.7× · PEG n/a · 50% evidence Relative strength 7.1/20 · Lead over its industry -9.7% · Lead over NIFTY 500 4.2% · 1 year 10.5% · 100% evidence · 2 of 12 weeks ahead Exact sum: 23.7 + 18.5 + 10.1 + 7.1 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Fineotex Chemical Ltd](https://www.sectoralpha.in/stocks/fineotex-chemical-ltd) FCL · leader · Evidence leans up · 96% evidence 59.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.3/35 · Revenue 91.5% · Profit 41% · Operating margin change -2 points · 88% evidence Capital efficiency 13.5/25 · ROCE 18.3% · Operating margin 16% · 100% evidence Valuation 5.7/20 · P/E 46.1× · PEG 1.92 · 100% evidence Relative strength 19.5/20 · Lead over its industry 34.1% · Lead over NIFTY 500 48.9% · 1 year 62.9% · 100% evidence · 12 of 12 weeks ahead Exact sum: 20.3 + 13.5 + 5.7 + 19.5 = 59 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [DMCC Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/dmcc-speciality-chemicals-ltd) DMCC · quiet · Evidence leans up · 93% evidence 55.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.9/35 · Revenue 72.1% · Profit 34.5% · Operating margin change -6.9 points · 100% evidence Capital efficiency 8.7/25 · ROCE 14.8% · Operating margin 4.2% · 100% evidence Valuation 16.1/20 · P/E 16.9× · PEG 0.44 · 65% evidence Relative strength 7.8/20 · Lead over its industry -12.3% · Lead over NIFTY 500 0.9% · 1 year -15.5% · 100% evidence · 9 of 12 weeks ahead Exact sum: 22.9 + 8.7 + 16.1 + 7.8 = 55.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Aarti Industries Ltd](https://www.sectoralpha.in/stocks/aarti-industries-ltd) AARTIIND · quiet · Evidence leans up · 100% evidence 55.2 out of 100 Growth Capital Valuation Relative
12. [Galaxy Surfactants Ltd](https://www.sectoralpha.in/stocks/galaxy-surfactants-ltd) GALAXYSURF · leader · Evidence leans up · 81% evidence 53.9 out of 100 Growth Capital Valuation Relative
13. [Pidilite Industries Ltd](https://www.sectoralpha.in/stocks/pidilite-industries-ltd) PIDILITIND · quiet · Evidence leans up · 100% evidence 53.0 out of 100 Growth Capital Valuation Relative
14. [DIC India Ltd](https://www.sectoralpha.in/stocks/dic-india-ltd) DICIND · breaking out · Evidence leans up · 81% evidence 53.0 out of 100 Growth Capital Valuation Relative
15. [Kronox Lab Sciences Ltd](https://www.sectoralpha.in/stocks/kronox-lab-sciences-ltd) KRONOX · breaking out · Evidence leans up · 74% evidence 51.8 out of 100 Growth Capital Valuation Relative
16. [Neogen Chemicals Ltd](https://www.sectoralpha.in/stocks/neogen-chemicals-ltd) NEOGEN · leader · Evidence leans up · 90% evidence 51.5 out of 100 Growth Capital Valuation Relative
17. [Chemcon Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/chemcon-speciality-chemicals-ltd) CHEMCON · breaking out · Evidence leans up · 85% evidence 51.1 out of 100 Growth Capital Valuation Relative
18. [Alkyl Amines Chemicals Ltd](https://www.sectoralpha.in/stocks/alkyl-amines-chemicals-ltd) ALKYLAMINE · quiet · Evidence leans down · 96% evidence 47.9 out of 100 Growth Capital Valuation Relative
19. [Grauer & Weil (India) Ltd](https://www.sectoralpha.in/stocks/grauer-weil-indialtd) GRAUWEIL · breaking out · Evidence leans down · 96% evidence 46.3 out of 100 Growth Capital Valuation Relative
20. [Paushak Ltd](https://www.sectoralpha.in/stocks/paushak-ltd) PAUSHAKLTD · losing its lead · Evidence leans down · 85% evidence 45.8 out of 100 Growth Capital Valuation Relative
21. [Innovassynth Technologies (India) Ltd](https://www.sectoralpha.in/stocks/innovassynth-technologies-indialtd) breaking out · Too little evidence to rank firmly · 53% evidence 44.0 out of 100 Growth Capital Valuation Relative
22. [Anupam Rasayan India Ltd](https://www.sectoralpha.in/stocks/anupam-rasayan-india-ltd) ANURAS · turning · Evidence leans down · 78% evidence 43.7 out of 100 Growth Capital Valuation Relative
23. [Platinum Industries Ltd](https://www.sectoralpha.in/stocks/platinum-industries-ltd) PLATIND · turning · Evidence leans down · 81% evidence 42.5 out of 100 Growth Capital Valuation Relative
24. [Vinati Organics Ltd](https://www.sectoralpha.in/stocks/vinati-organics-ltd) VINATIORGA · quiet · Evidence leans down · 82% evidence 42.4 out of 100 Growth Capital Valuation Relative
25. [Amal Ltd](https://www.sectoralpha.in/stocks/amal-ltd) AMAL · quiet · Evidence leans down · 68% evidence 41.5 out of 100 Growth Capital Valuation Relative
26. [Amines & Plasticizers Ltd](https://www.sectoralpha.in/stocks/amines-plasticizers-ltd) AMNPLST · quiet · Evidence leans down · 81% evidence 41.1 out of 100 Growth Capital Valuation Relative
27. [Transpek Industry Ltd](https://www.sectoralpha.in/stocks/transpek-industry-ltd) TRANSPEK · losing its lead · Evidence leans down · 63% evidence 38.6 out of 100 Growth Capital Valuation Relative
28. [Vishnu Chemicals Ltd](https://www.sectoralpha.in/stocks/vishnu-chemicals-ltd) VISHNU · losing its lead · Evidence leans down · 100% evidence 38.4 out of 100 Growth Capital Valuation Relative
29. [Clean Science & Technology Ltd](https://www.sectoralpha.in/stocks/clean-science-technology-ltd) CLEAN · breaking out · Evidence leans down · 85% evidence 38.1 out of 100 Growth Capital Valuation Relative
30. [Thirumalai Chemicals Ltd](https://www.sectoralpha.in/stocks/thirumalai-chemicals-ltd) TIRUMALCHM · quiet · Most evidence points down · 68% evidence 27.2 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Speciality Chemicals](https://www.sectoralpha.in/sectors/speciality-chemicals), all 30 compared on one page. ## Which companies are close to Sunshield Chemicals in size? Sunshield Chemicals is the 22nd largest of 30 Speciality Chemicals companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Thirumalai Chemicals, Platinum Industries and Vikram Thermo (India). Just below it: Amines & Plasticizers, Kronox Lab Sciences and Transpek Industry. ### Speciality Chemicals companies close in size

1. [Thirumalai Chemicals Ltd](https://www.sectoralpha.in/stocks/thirumalai-chemicals-ltd) ₹1,378 crore
2. [Platinum Industries Ltd](https://www.sectoralpha.in/stocks/platinum-industries-ltd) ₹1,215 crore
3. [Vikram Thermo (India) Ltd](https://www.sectoralpha.in/stocks/vikram-thermo-indialtd) ₹1,129 crore
4. Sunshield Chemicals Ltd ₹882 crore
5. [Amines & Plasticizers Ltd](https://www.sectoralpha.in/stocks/amines-plasticizers-ltd) ₹782 crore
6. [Kronox Lab Sciences Ltd](https://www.sectoralpha.in/stocks/kronox-lab-sciences-ltd) ₹691 crore
7. [Transpek Industry Ltd](https://www.sectoralpha.in/stocks/transpek-industry-ltd) ₹682 crore

[All 30 Speciality Chemicals companies, largest first](https://www.sectoralpha.in/sectors/speciality-chemicals#all-companies)

### Companies close in size in other industries

1. [Freshara Agro Exports Ltd](https://www.sectoralpha.in/stocks/freshara-agro-exports-ltd) ₹882 crore · Food - Processing - Spices/Pickles
2. [Sejal Glass Ltd](https://www.sectoralpha.in/stocks/sejal-glass-ltd) ₹882 crore · Glass & Glass Products
3. Sunshield Chemicals Ltd ₹882 crore
4. [Gayatri Projects Ltd](https://www.sectoralpha.in/stocks/gayatri-projects-ltd) ₹880 crore · Construction - Civil/Turnkey
5. [Kalyani Cast-Tech Ltd](https://www.sectoralpha.in/stocks/kalyani-cast-tech-ltd) ₹878 crore · Castings - Steel/Alloy

## What else do people ask about Sunshield Chemicals? ### What is Sunshield Chemicals's share price today? Sunshield Chemicals Ltd's share price is ₹1,030.00, −0.1% over the past year. The whole company is worth ₹906 Cr on the market. In the last 52 weeks it traded between ₹746 to ₹1,277; today it is 54% of the way up from the low, 1.6% below its 200-day average (as of 3 November 2026). ### What were Sunshield Chemicals's latest quarterly results? Sunshield Chemicals Ltd reported revenue of ₹127 Cr and net profit of ₹13.0 Cr for the Jun 2026 quarter. Revenue rose 11.4% and profit rose 85.7% compared with a year earlier. Earnings per share were ₹15.34. The operating margin was 16.0%, 5.0 percentage points higher than a year earlier (as of 3 November 2026). ### What is Sunshield Chemicals's market cap? Sunshield Chemicals Ltd's market capitalisation is ₹906 Cr at a share price of ₹1,030.00. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Sunshield Chemicals performing? Sunshield Chemicals Ltd's share price has been rising for 22 weeks. In its latest quarter, revenue rose 11.4% and profit rose 85.7% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 4 weeks running (as of 3 November 2026). ### Will Sunshield Chemicals's share price go up? This page does not forecast Sunshield Chemicals Ltd's share price. What it shows instead: the share price is ₹1,030.00, and it has been rising for 22 weeks. Its P/E of 24.9× is higher than 17% of its own last 8 years (as of 3 November 2026). ### Who owns Sunshield Chemicals? Promoters own 66.6% of Sunshield Chemicals Ltd, foreign institutions 9.1%, domestic institutions 0.0% and the public 24.3% (latest quarter). The biggest change over the last two years: Promoters raised their stake by 4.2 percentage points over 8 quarters (as of 3 November 2026). ### Does Sunshield Chemicals have too much debt? No, Sunshield Chemicals Ltd has little debt: its debt is 0.00× its equity, and its operating profit is 10 times its interest bill. FY26 borrowings were ₹0.0 Cr against equity of ₹252 Cr. So the returns on this page come from the business, not borrowed money (as of 3 November 2026). ### Where is Sunshield Chemicals in its business cycle? Sunshield Chemicals Ltd's FY26 operating margin was 12.0%, against a 13-year range of 1.8% to 15.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 16.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Sunshield Chemicals story? The main question: yearly earnings per share moved +103.1% while the share price moved −0.1%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Sunshield Chemicals a stock worth studying right now? What the numbers show: Sunshield Chemicals Ltd's results are improving, while its P/E is near the low end of its own history over 8.4 years, higher than only 17% of past readings. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a Sunshield Chemicals share price forecast for 2026? What would change the story: Operating margin falls back below 8% for two consecutive quarters while revenue stays above 100 Cr per quarter, ruling out the operating leverage thesis and implying a structural cost impairment not visible from the GPM stability. Or borrowings reaccelerate above 120 Cr while quarterly operating cash flow drops below 10 Cr, indicating the capital spending cycle is reigniting without revenue conversion. This is research, not advice. We’re not SEBI-registered.